Remove Chest Pain Remove Plaque Remove Technology
article thumbnail

CMS Updates Medicare Coverage for AI-Coronary Plaque Analysis

DAIC

15 , 2024 — Four of the seven Medicare Administrative Contractors (MACs) have released final local coverage determinations (LCD) for AI-Coronary Plaque Analysis (AI-CPA). tim.hodson Wed, 10/16/2024 - 12:36 Oct. The four contractors for the U.S.

CMS 52
article thumbnail

HeartFlow Achieves Landmark Milestone of 250,000 Patients Assessed for Coronary Artery Disease (CAD) with FFRCT Analysis

DAIC

With more than 500 peer-reviewed publications, the HeartFlow FFR CT Analysis remains unparalleled in precision coronary care, as supported by the ACC/AHA Chest Pain Guidelines, to improve treatment plans and outcomes. 2021 ACC/AHA Chest Pain Guidelines. said John Farquhar, Chief Executive Officer at HeartFlow.

article thumbnail

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

ET Murphy Ballroom 4 Health 360x Registry: Scalable Workforce for Equitable Access to Point of Care Decentralized Clinical Trials Prevalence of Cardiovascular Disease and Risk Factors Among National Football League Alumni and Their Family Members: Results from the Huddle Study Hózhó (Heart Failure Optimization at Home to Improve Outcomes): A Pragmatic (..)

article thumbnail

30 yo woman with trapezius pain. HEART Pathway = 0. Computer "Normal" ECG. Reality: ECG is Diagnostic of LAD Occlusion.

Dr. Smith's ECG Blog

She was treated medically for NonSTEMI, pending next day cath, which showed ulcerated plaque and a 60% thrombotic stenosis in the LAD distal to the first diagonal. Wall motion abnormalities are very hard to see, even with advanced Speckle Tracking technology. Echo may be normal ( especially if the patient no longer has chest pain ).

STEMI 40
article thumbnail

HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients

DAIC

2-4 HeartFlow’s non-invasive FFR CT technology has emerged as a leading frontline strategy for accurately diagnosing hemodynamically significant coronary lesions in patients suspected of having CAD. 5 Revascularization to improve blood flow to the heart has been shown to reduce mortality in stable chest pain patients.

article thumbnail

Embracing Cardiac Imaging: Overcoming Barriers, Adopting In-house Solutions, and Navigating Future Advancements

DAIC

Cardiac CT scans, recommended by the American College of Cardiology (ACC) and the American Heart Association (AHA) as the primary testing strategy for patients with acute chest pain, are necessary for evaluating cases and determining treatment plans. Advanced scanners provide detailed insights into plaque progression and stabilization.

article thumbnail

Agepha Pharma and Caristo Diagnostics Team Up to Fight Coronary Inflammation

DAIC

mg tablets), together with Caristo Diagnostics , a leading cardiac disease diagnostics company with the novel CaRi-Heart technology to visualize and quantify coronary inflammation, announced today their collaboration to improve awareness and clinical education about the central role of inflammation in coronary artery disease. mg tablets.”